Safety of Peanut Oral Immunotherapy in Preschoolers at a Pediatric Academic Food Allergy Center

Following publication of the IMPACT study, we launched an early peanut oral immunotherapy (e-POIT) program for peanut-allergic children 6 months to 4 years of age. We aimed to capture adverse events (AEs) related to dosing for all e-POIT patients.

Source: Journal of Allergy and Clinical Immunology - February 1, 2024 Category: Allergy & Immunology Authors: Brian Vickery, Codi Horton, Chelsea Leef, Shasha Bai, Idil Ezhuthachan, Tricia Lee, Gerald Lee, Melinda Rathkopf Source Type: research